We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$201M
AUM Growth
+$21.6M
Cap. Flow
+$4.01M
Cap. Flow %
2%
Top 10 Hldgs %
34.54%
Holding
94
New
3
Increased
25
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$1.45M
2
QCOM icon
Qualcomm
QCOM
+$1.25M
3
GSK icon
GSK
GSK
+$958K
4
JCI icon
Johnson Controls International
JCI
+$689K
5
SLB icon
SLB Ltd
SLB
+$507K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$720K
2
DVN icon
Devon Energy
DVN
+$514K
3
JNJ icon
Johnson & Johnson
JNJ
+$430K
4
CNI icon
Canadian National Railway
CNI
+$342K
5
PRGO icon
Perrigo
PRGO
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Industrials 18.92%
3 Technology 17.72%
4 Energy 14.64%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$611B
$10.8M 5.36%
106,442
+4,496
+4% +$416K
PG icon
2
Procter & Gamble
PG
$349B
$8.54M 4.25%
104,902
-2,500
-2% -$204K
JNJ icon
3
Johnson & Johnson
JNJ
$609B
$7.26M 3.61%
79,277
-4,666
-6% -$430K
MMM icon
4
3M
MMM
$83.4B
$6.59M 3.28%
56,163
-3,153
-5% -$336K
EMR icon
5
Emerson Electric
EMR
$78.2B
$6.22M 3.1%
88,611
-2,345
-3% -$157K
CVX icon
6
Chevron
CVX
$373B
$6.1M 3.04%
48,859
-148
-0.3% -$17.9K
ADP icon
7
Automatic Data Processing
ADP
$102B
$5.99M 2.98%
84,377
-940
-1% -$63.2K
CVS icon
8
CVS Health
CVS
$137B
$5.96M 2.97%
83,342
-300
-0.4% -$19.3K
CNI icon
9
Canadian National Railway
CNI
$78.3B
$5.93M 2.95%
103,962
-6,220
-6% -$342K
NVS icon
10
Novartis
NVS
$293B
$5.88M 2.93%
81,623
-558
-0.7% -$38.8K
ATR icon
11
AptarGroup
ATR
$8.46B
$5.77M 2.87%
85,061
-1,385
-2% -$88.4K
INTC icon
12
Intel
INTC
$478B
$4.45M 2.21%
171,288
-1,800
-1% -$43.5K
PEP icon
13
PepsiCo
PEP
$187B
$4.04M 2.01%
48,706
+30
+0.1% +$2.49K
HD icon
14
Home Depot
HD
$338B
$3.98M 1.98%
48,395
-2,384
-5% -$186K
HP icon
15
Helmerich & Payne
HP
$3.41B
$3.82M 1.9%
45,465
+5,870
+15% +$457K
EMC
16
DELISTED
EMC CORPORATION
EMC
$3.59M 1.79%
142,818
-385
-0.3% -$9.33K
ORCL icon
17
Oracle
ORCL
$364B
$3.5M 1.74%
91,585
-1,160
-1% -$39.9K
ROK icon
18
Rockwell Automation
ROK
$51.4B
$3.44M 1.71%
29,099
+3,510
+14% +$390K
GSK icon
19
GSK
GSK
$104B
$3.38M 1.68%
50,710
+14,768
+41% +$958K
AAPL icon
20
Apple
AAPL
$4.9T
$3.29M 1.64%
164,360
+24,780
+18% +$468K
GE icon
21
GE Aerospace
GE
$364B
$3.11M 1.55%
23,173
-250
-1% -$31.5K
DE icon
22
Deere & Co
DE
$161B
$3.07M 1.53%
33,590
-3,860
-10% -$327K
COV
23
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.98M 1.48%
43,690
-380
-0.9% -$24.7K
RTX icon
24
RTX Corp
RTX
$261B
$2.89M 1.44%
40,400
+7,126
+21% +$486K
SLB icon
25
SLB Ltd
SLB
$70.3B
$2.89M 1.44%
32,078
+5,615
+21% +$507K
1
2 3 4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q4 2013 Portfolio in Review

As of Q4 2013, Brian C. Broderick held 94 positions worth $201M, up 12% from $179M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brian C. Broderick's Q4 2013 filing shows 3 new, 25 increased, 34 reduced and 3 closed positions. Its largest new stake was Epizyme, Inc: 50,000 shares worth $1.04M. The largest sale was Teva Pharmaceuticals, an estimated $720K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q4 2013 buy was Epizyme, Inc: 50,000 shares worth $1.04M.
  • Brian C. Broderick added most to Qualcomm in Q4 2013, an estimated $1.25M increase.
  • Brian C. Broderick's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $720K.
  • Brian C. Broderick fully exited Devon Energy in Q4 2013, selling an estimated $514K.
  • Brian C. Broderick's ten largest holdings make up 35% of its $201M portfolio in Q4 2013.
  • Brian C. Broderick opened 3 new positions and closed 3 in Q4 2013.
  • Brian C. Broderick's portfolio value rose 12% quarter-over-quarter to $201M.

Based on Brian C. Broderick's 13F filing for Q4 2013, filed 27 Feb 2014.